Bevacizumab and albumin-bound paclitaxel treatment in metastatic breast cancer.
about
Phase 1-2 study of docetaxel plus aflibercept in patients with recurrent ovarian, primary peritoneal, or fallopian tube cancer.Targeted delivery of albumin bound paclitaxel in the treatment of advanced breast cancer.Lymphangiogenesis and lymphatic metastasis in breast cancer.Nab-paclitaxel efficacy in the orthotopic model of human breast cancer is significantly enhanced by concurrent anti-vascular endothelial growth factor A therapy.Tumour-targeted nanomedicines: principles and practice.Nanoparticle albumin-bound paclitaxel combined with cisplatin as the first-line treatment for metastatic esophageal squamous cell carcinomaSWOG S0800 (NCI CDR0000636131): addition of bevacizumab to neoadjuvant nab-paclitaxel with dose-dense doxorubicin and cyclophosphamide improves pathologic complete response (pCR) rates in inflammatory or locally advanced breast cancer.Novel combinations for the treatment of metastatic breast cancer.Residual breast cancer diagnosed by MRI in patients receiving neoadjuvant chemotherapy with and without bevacizumab.Albumin-bound paclitaxel: the benefit of this new formulation in the treatment of various cancers.Safety and efficacy evaluation of albumin-bound paclitaxel.Evaluating the role of nab-paclitaxel (Abraxane) in women with aggressive metastatic breast cancer.
P2860
Q30424925-C4D90809-CB0A-4ED4-8D13-6E66E97B5EC2Q33916040-F2632732-8252-4AF3-BAB7-9D7E9E5C1F9BQ33940058-1AC5DDED-0314-417F-AC77-999344C1285AQ36661727-C0025450-1BF4-46A9-ACE2-157FE520F37FQ36858135-83D4EB26-8275-4BC3-82B1-87E657B64F3DQ36891363-1BF4D207-38B6-444E-9AE6-C63F71281D21Q37131869-96A55E04-B84F-465B-A621-536E2A3BBB42Q37307168-58D015EE-00EA-4D0A-A715-52C6681DBC44Q37450606-22606EE1-AE5E-4E72-BFD2-294B3B0A46E0Q37875561-0264DB40-90FF-4647-8C0A-B5A8763A0FECQ38190090-234B08EA-CDA4-4B8F-81E6-C271CD07CBA5Q39243591-FD97FBD9-391F-4183-8E01-BACFCD1F4523
P2860
Bevacizumab and albumin-bound paclitaxel treatment in metastatic breast cancer.
description
2007 nî lūn-bûn
@nan
2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Bevacizumab and albumin-bound paclitaxel treatment in metastatic breast cancer.
@ast
Bevacizumab and albumin-bound paclitaxel treatment in metastatic breast cancer.
@en
Bevacizumab and albumin-bound paclitaxel treatment in metastatic breast cancer.
@nl
type
label
Bevacizumab and albumin-bound paclitaxel treatment in metastatic breast cancer.
@ast
Bevacizumab and albumin-bound paclitaxel treatment in metastatic breast cancer.
@en
Bevacizumab and albumin-bound paclitaxel treatment in metastatic breast cancer.
@nl
prefLabel
Bevacizumab and albumin-bound paclitaxel treatment in metastatic breast cancer.
@ast
Bevacizumab and albumin-bound paclitaxel treatment in metastatic breast cancer.
@en
Bevacizumab and albumin-bound paclitaxel treatment in metastatic breast cancer.
@nl
P2093
P356
P1476
Bevacizumab and albumin-bound paclitaxel treatment in metastatic breast cancer.
@en
P2093
Bichlien Nguyen
Cheryl I Jacobs
James R Waisman
John S Link
P304
P356
10.3816/CBC.2007.N.039
P407
P577
2007-10-01T00:00:00Z